Valuation : Aoxing Pharmaceutical Company, Inc.

Market Cap 23.62M 20.33M 19.13M 17.47M 32.69M 2.23B 32.77M 226M 87.7M 1.14B 88.71M 86.78M 3.69B P/E 2015
20.1x
P/E 2016 23.2x
Enterprise Value 42.18M 36.3M 34.15M 31.2M 58.36M 3.98B 58.52M 404M 157M 2.04B 158M 155M 6.58B EV / Sales 2015
5.77x
EV / Sales 2016 2.11x
Free-Float
100%
Yield 2015 *
-
Yield 2016 -
05/08/17 Aoxing Pharmaceutical Company, Inc. Executive Changes CI
16/05/17 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2017 CI
14/02/17 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2016 CI
14/11/16 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for First Quarter Ended Sept. 30, 2016 CI
05/10/16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Year Ended June 30, 2016 CI
16/05/16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2016 CI
09/02/16 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2015; Provides Earnings Guidance for the Fiscal Year 2016 CI
01/02/16 Aoxing Pharmaceutical Company, Inc. Announces Executive Changes CI
11/12/15 Aoxing Pharmaceutical Company, Inc. to Supply Zhongtongan to the Insurance System for the City of Shanghai CI
05/12/15 Aoxing Pharmaceutical Company, Inc. Announces Opening of its New Narcotic and Psychotropic Drug Research Center CI
02/12/15 Aoxing Pharmaceutical Company, Inc. Announces Management Changes CI
14/11/15 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended September 30, 2015 CI
13/10/15 Aoxing Pharmaceutical Company, Inc. Auditor Raises 'Going Concern' Doubt CI
1 week+23.81%
1 month-25.71%
3 months-50.00%
6 months-64.38%
Current year-21.21%
1 week 0
Extreme 0.0026
0
1 month 0
Extreme 0.0011
0
Current year 0
Extreme 0.0011
0.01
1 year 0
Extreme 0.0011
0.01
3 years 0
Extreme 0.0011
0.02
5 years 0
Extreme 1.0E-6
0.02
10 years 0
Extreme 0
0.66
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+23.81%-52.73%+136.36% 991K
+0.50%-3.33%-32.33%-54.28% 1.86B
+1.78%+5.61% - - 1.84B
+2.78%+4.18%-17.56%+187.56% 1.22B
+2.32%+3.58%-47.43%+21.45% 1.19B
-0.29%-0.77%+198.82%+926.55% 1.1B
+1.65%+1.11%+54.50%+39.67% 1.01B
-1.15%-5.40%-12.16%+61.16% 827M
+0.63%+0.83%+32.30%+206.33% 813M
-10.00%-6.90%+47.27%-24.65% 583M
Average -0.18%+1.97%+18.96%+166.68% 1.05B
Weighted average by Cap. +0.52%+0.51%+20.83%+164.51%

Financials

2015 2016
Net sales 25.48M 21.93M 20.63M 18.85M 35.25M 2.41B 35.35M 244M 94.6M 1.23B 95.68M 93.6M 3.98B 32.33M 27.82M 26.17M 23.91M 44.73M 3.05B 44.85M 309M 120M 1.57B 121M 119M 5.05B
Net income 5.49M 4.73M 4.45M 4.06M 7.6M 519M 7.62M 52.57M 20.4M 266M 20.63M 20.18M 857M 2.06M 1.77M 1.67M 1.52M 2.85M 195M 2.86M 19.72M 7.65M 99.85M 7.74M 7.57M 322M
Net Debt 24.8M 21.34M 20.08M 18.34M 34.32M 2.34B 34.41M 237M 92.08M 1.2B 93.14M 91.11M 3.87B 18.56M 15.97M 15.03M 13.73M 25.68M 1.75B 25.75M 178M 68.9M 899M 69.69M 68.17M 2.9B
Logo Aoxing Pharmaceutical Company, Inc.
Aoxing Pharmaceutical Company, Inc., through its subsidiary, InfoEd Tech Limited, provides educational technology solutions aimed at overcoming language barriers in the Asia Pacific region. By converting training programs into video formats and utilizing artificial intelligence (AI) for multilingual support, it offers accredited training programs that cater to the needs of professionals across various industries.
Employees
-
Date Price Change Volume
01/09/26 USD 0.002600 0.00% 100
31/08/26 USD 0.002600 +23.81% 1,480
  1. Stock Market
  2. Stocks
  3. AOXG Stock